MDEA: Difference between revisions
>Unity m Grammatics |
>Unity m Grammatics |
||
Line 164: | Line 164: | ||
There is an increased risk of serotonin syndrome when MDEA is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, if MDEA is taken with SSRIs and SNRIs, the MDEA will be significantly less powerful or may have no distinguishable effects at all. | There is an increased risk of serotonin syndrome when MDEA is taken with many antidepressants, particularly selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). Additionally, if MDEA is taken with SSRIs and SNRIs, the MDEA will be significantly less powerful or may have no distinguishable effects at all. | ||
== | ==Legal status== | ||
{{LegalStub}} | {{LegalStub}} | ||
*'''Brazil''' | *'''Brazil:''' MDEA is illegal to possess, produce or sell as it is listed on Portaria SVS/MS nº 344 as "MDE".<ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref> | ||
*'''United Kingdom:''' MDEA is a Class A drug. | *'''United Kingdom:''' MDEA is a Class A drug.{{citation needed}} | ||
*'''United States:''' MDEA is a Schedule I drug. | *'''United States:''' MDEA is a Schedule I drug.{{citation needed}} | ||
==See also== | ==See also== |